NCT06203249View on ClinicalTrials.gov

Microecology and Immunity in Patients With Anti-MDA5 Antibody Positive Dermatomyositis and Interstitial Lung Disease

RecruitingOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

January 20, 2024

Primary Completion Date

December 30, 2025

Study Completion Date

November 25, 2026

Conditions
MicrobiomeImmune FunctionAnti-MDA5 Antibody Positive Dermatomyositis
Trial Locations (1)

100853

RECRUITING

PLA, Beijing

All Listed Sponsors
lead

Chinese PLA General Hospital

OTHER